Bachtell

Cresco Labs Announces Fourth Quarter & Full Year 2022 Results

Retrieved on: 
Thursday, March 16, 2023
Natural Resources, Alternative Medicine, Other Retail, Health, Hemp, Food, Beverage, Cannabis, Retail, Cresco Labs, FSE, Eastern Time Zone, Webcast, SEED, CL, ICEC, Depreciation, Partnership, Congress, Rationalization, Cresco, Organization, EBITDA, Bank statement, Bachtell, Student, GAAP, Growth, Tax, SEDAR, Total, Corona Labs Inc., Entrepreneurship, CSE, Drug, Video game, Cryptocurrency, Holding company, Pharmaceutical industry, Commercial property, Bank, Security (finance)

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), a vertically integrated, multi-state operator and the No.

Key Points: 
  • Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), a vertically integrated, multi-state operator and the No.
  • 1 producer of branded cannabis products in the industry, today released its financial results for the quarter and year ended December 31, 2022.
  • “I want to congratulate the Cresco Labs team on how well they tackled the challenges of 2022.
  • None of the challenges of 2022 change the long-term thesis and opportunity that is cannabis,” said Charles Bachtell, CEO and Co-founder of Cresco Labs.

Cresco Labs to Gain Leadership Position in Massachusetts Through Acquisition of Cultivate

Retrieved on: 
Thursday, March 18, 2021
Tobacco, Retail, Alternative medicine, Health, Cannabis, Cannabis in Illinois, Cresco Labs, Bachtell, Cresco, Cannabis in Massachusetts

Through this acquisition, Cresco Labs will immediately vault to a top 3 share position in Massachusetts, the third $1B+ cannabis market where weve achieved this status, said Charles Bachtell, CEO of Cresco Labs.

Key Points: 
  • Through this acquisition, Cresco Labs will immediately vault to a top 3 share position in Massachusetts, the third $1B+ cannabis market where weve achieved this status, said Charles Bachtell, CEO of Cresco Labs.
  • Cultivate has been a trailblazer and an operational standout since the early days of the Massachusetts market.
  • Mr. Bachtell continued, This will also mark the fourth state in which we operate the maximum number of retail stores.
  • At a period of industry inflection, we are cementing our leadership in a deliberate manner as the most important company in cannabis.

Cresco Labs Announces Upcoming Conference Participation

Retrieved on: 
Monday, August 24, 2020
Alternative medicine, Health, Retail, Tobacco, Specialty, Cannabis, Cannabis in Illinois, Cresco Labs, Cresco, OTC Markets Group, Cannabis and religion, Bachtell

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (Cresco or the Company), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following conferences:

Key Points: 
  • Cresco Labs (CSE:CL) (OTCQX:CRLBF) (Cresco or the Company), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following conferences:
    August 25th, 2020 Echelon Wealth Partner US MSO Cannabis Conference Charlie Bachtell, CEO and Co-Founder, will present on the Companys behalf.
  • August 26th, 2020 Needham Virtual Cannabis 1x1 Conference Management will participate in virtual one-on-one meetings.
  • September 15-17th, 2020 Cantor Fitzgerald Global Virtual Healthcare Conference Management will attend one-on-one meetings and Charlie Bachtell, CEO and Co-Founder, will present on the Companys behalf.
  • Cresco Labs is one of the largest vertically-integrated multi-state cannabis operators in the United States.

Cresco Labs Closes Sale-and-Leaseback for Massachusetts Facility and Expands Real Estate Partnership with Innovative Industrial Properties

Retrieved on: 
Wednesday, July 1, 2020
Retail, Commercial Building & Real Estate, Construction & Property, Other Retail, Cannabis, Cannabis in Illinois, Cresco Labs, Cresco, Bachtell

Consideration for the sale was approximately $29 million, which includes $21 million in funding for tenant improvements.

Key Points: 
  • Consideration for the sale was approximately $29 million, which includes $21 million in funding for tenant improvements.
  • Cresco Labs CEO and Co-founder Charlie Bachtell said, IIP has proven to be a reliable partner, and we are thrilled to work with them for a fifth lease.
  • This transaction, along with our expanded real estate partnership with IIP is allowing us to continue building out Crescos presence in three exciting markets: Massachusetts, Michigan, and Ohio.
  • Cresco Labs is one of the largest vertically-integrated multi-state cannabis operators in the United States.